Includes Interferon gamma-1b, marketed as Actimmune.
More information
More information
Sites 2
Manufacturer's information about this protein agent approved by the US FDA for the treatment of chronic granulomatous disease, and severe, malignant osteopetrosis.
Features information about dosage, usage, warnings, and side effects.
Features information about dosage, usage, warnings, and side effects.
Manufacturer's information about this protein agent approved by the US FDA for the treatment of chronic granulomatous disease, and severe, malignant osteopetrosis.
Last update:
October 17, 2016 at 22:49:55 UTC
Check out
Regional: Europe: United Kingdom: England: Cornwall: Polzeath
- Recently edited by merlin1
- Recently edited by merlin1